Tvardi Therapeutics

Tvardi therapeutics email format

Verified email-pattern data for Tvardi Therapeutics is currently limited. You can still use the company insights and contact sections below.
Tvardi is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. STAT3 is a central mediator across critical fibrotic signaling pathways that drive uncontrolled deposition, proliferation, survival and immune suppression. STAT3 is also positioned at the intersection of many signaling pathways integral to the survival and immune evasion of cancer cells. The company is conducting Phase 2 clinical trials in fibrosis-driven diseases with high unmet need: idiopathic pulmonary fibrosis (NCT05671835) and hepatocellular carcinoma (NCT05440708).

Company Details

Employees
18
Founded
-
Address
2450 Holcombe Blvd, Suite X, Houston,tx 77021,united States
Phone
832-413-1362
Industry
Biotechnology Research
HQ
Houston, TX
Looking for a particular Tvardi Therapeutics employee's phone or email?

Tvardi Therapeutics Questions

Top Tvardi Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant